Cite
MLA Citation
S. M. Horwitz et al.. “THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS.” Hematological oncology, vol. 39, n.d., p. n/a. http://access.bl.uk/ark:/81055/vdc_100133622930.0x000041